Abstract

Introduction: Liver transplantation (LT) is considered as the standard treatment for end stage liver disease. However, there is a problem of donor shortage, and the need of grafts from marginal donors has increased. Attenuation of ischemia and reperfusion injury (IRI) in such marginal donors is crucial for less possibility of primary non-function and the graft loss. There have been some reports that hydrogen (H2) shows the antioxidant and anti-inflammatory effects, and eventually prevents IRI, in some non-hepatic transplant models[1][2]. Therefore, we investigated whether the H2 attenuates IRI in LT model using rats. Methods: We made and used the H2 rich water bath (HRWB), in which the H2 ion was dissolved in the UW solution. Isogenic LT model of Lewis rats was used. Without arterial reconstruction, orthotopic LT was performed according to Kamada’s cuff method. The animals were divided into four groups; sham operation (Sham), not preserved (NP), preserved 12 hours in UW solution (UW), preserved 12 hours in H2 rich UW solution (UW+H2). H2 ion solution in the graft liver was measured every hour after preservation in the preliminary study. Blood and tissue samples were corrected 6 hours after the reperfusion. Hepatic enzymes in serum were measured. Pathological findings including the expressions of cytokines and heme oxygenase-1 (HO-1) in liver tissues were evaluated.FigureResult: H2 concentration of graft tissue increased depending on the storing time in the HRWB, and it became plateau after 1 hour. AST, ALT, and LDH levels of serum showed significantly lower in UW+H2 groups. In the UW group, liver histology showed focal hemorrhage, cell ballooning, and infiltration of neutrophils and macrophages, and those findings were much attenuated in the UW+H2 group. UW+H2 group also showed less oxidative damage and hepatocyte apoptosis. UW+H2 groups tended to have lower proinflammatory cytokines and higher HO-1 levels in mRNA expressions, and protein levels of HO-1 increased significantly. Conclusion: By using the HRWB, sufficient H2 distribution in the liver graft was obtained. Storage of the liver grafts in H2 rich UW solution presented superior functional and morphologic protection for IRI. Up-regulation of HO-1 was suggested as one mechanism of this effect. Result of our present study demonstrated that H2 rich solution decrease oxidative stress and inflammatory changes by IRI in rat LT model.

Highlights

  • Liver transplantation (LT) is considered the standard treatment for end-stage liver disease, but ideal donors remain in limited supply, resulting in an unavoidable increase in the need to use grafts from marginal donors

  • Hydrogen levels in the cold preservation solution and liver tissues stored in hydrogen-rich water bath Figure 1b shows the hydrogen concentration of the University of Wisconsin (UW) solution prepared in the hydrogen-rich water bath

  • Hydrogen-rich UW reduced the liver injury Figure 2a shows that the Serum aspartate aminotransferase (AST), Alanine aminotransferase (ALT) and lactic dehydrogenase (LDH) levels of the UW group were significantly higher than those in Hydrogen-rich UW reduced injury-related Messenger RNA (mRNA) and protein expression in liver tissue In the measurement of the mRNA levels of proinflammatory cytokines in liver tissues using reversetranscriptase polymerase chain reaction (RT-PCR), the Chemokine ligand 2 (CCL2), intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 levels tended to be lower in the UW + H2 group than in the UW group (Fig. 3a)

Read more

Summary

Introduction

Liver transplantation (LT) is considered the standard treatment for end-stage liver disease, but ideal donors remain in limited supply, resulting in an unavoidable increase in the need to use grafts from marginal donors. The attenuation of ischemia-reperfusion injury (IRI) in such marginal donors is crucial for reducing the possibility of the primary non-function of grafts and graft loss. The innovation of immunosuppression therapies, perioperative management and surgical procedures and materials, including preservation solutions, have improved the outcomes of LT, the primary non-function of a graft and graft loss still occur at reported rates of 3.8% [2] to 5.8% [3]. Because of the vulnerability of such marginal donors to IRI, reducing the risk of IRI is crucial for preventing the primary non-function of grafts and graft loss [6]. Some animal studies have attempted to identify agents that prevent IRI, but most have failed to find a foothold in the clinical routine [7, 8].

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.